KathleenKemmerMD

PubMed

• 34 citations
  Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
  Elias, A., Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura J. van't Veer, Douglas Yee, Stacy L. Moulder, Anne M. Wallace, A. Jo Chien, Claudin...> ;Nature Communications. 2021 Nov 5
• 12 citations
  Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
  Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kath...> ;NPJ Breast Cancer. 2021 Oct 5
• 37 citations
  Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
  W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
• 118 citations
  Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
  Lajos Pusztai, Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace, Erica String-Reasor, Judy C. Boughey, A. Jo Chien, Anthony D. Elias, Heather Beckwi...> ;Cancer Cell. 2021 Jul 12
• 99 citations
  Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Can...
  Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain, Yunn Yi Chen, Gregor Krings, Shi Wei, Shuko Harada, Brian Datnow, Ol...> ;JAMA Oncology. 2020 Sep 1
• 378 citations
  Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adapt...
  Rita Nanda, Minetta C. Liu, Christina Yau, Rebecca Shatsky, Lajos Pusztai, Anne M. Wallace, A. Jo Chien, Andres Forero-Torres, Erin D. Ellis, HS Han, Amy S. Clark, Kat...> ;JAMA Oncology. 2020 May 1
• 58 citations
  MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2–positive and/or hormone receptor–negative bre...
  A. Jo Chien, Debasish Tripathy, Kathy S. Albain, W. Fraser Symmans, Hope S. Rugo, Michelle E. Melisko, Anne M. Wallace, Richard Schwab, Teresa Helsten, Andres Forero-T...> ;Journal of Clinical Oncology. 2020 Apr 1
• 21 citations
  Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
  Archana Machireddy, Guillaume Thibault, Alina Tudorica, Aneela Afzal, May Mishal, Kathleen Kemmer, Arpana Naik, Megan L. Troxell, Eric Goranson, Karen Y. Oh, Nicole Ro...> ;Tomography. 2019 Mar 1
• 26 citations
  Implementing a comprehensive translational oncology platform: from molecular testing to actionability
  Zahi Mitri, Swapnil Parmar, Brett Johnson, Annette Kolodzie, Jamie M. Keck, Max Morris, Alexander R. Guimaraes, Brooke Beckett, Uma Borate, Charles D. Lopez, Kathleen ...> ;Journal of Translational Medicine. 2018 Dec 14
• 364 citations
  Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;The Lancet. Oncology. 2017 Dec 1
• 46 citations
  DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response.
  Guillaume Thibault, Alina Tudorica, Aneela Afzal, Stephen Y. Chui, Arpana Naik, Megan L. Troxell, Kathleen Kemmer, Karen Y. Oh, Nicole Roy, Neda Jafarian, Megan L. Hol...> ;Tomography. 2017 Mar 1
• 109 citations
  Adaptive Randomization of Neratinib in Early Breast Cancer.
  John W Park, Minetta C Liu, Douglas Yee, Christina Yau, Laura J van 't Veer, W Fraser Symmans, Melissa Paoloni, Jane Perlmutter, Nola M Hylton, Michael Hogarth, Angela...> ;The New England Journal of Medicine. 2016 Jul 7
• 393 citations
  Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
  Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, Christina Yau, Laura J. van't Veer, Meredith Buxton, Michael Hogarth, Nola M. Hylton, Melissa Paoloni, Jane Pe...> ;The New England Journal of Medicine. 2016 Jul 6
• 83 citations
  Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.
  Alina Tudorica, Karen Y. Oh, Stephen Y. Chui, Nicole Roy, Megan L. Troxell, Arpana Naik, Kathleen Kemmer, Yiyi Chen, Megan L. Holtorf, Aneela Afzal, Charles S. Springe...> ;Translational Oncology. 2016 Feb 1
• 257 citations
  KIT mutations are common in testicular seminomas.
  Kathleen Kemmer, Christopher L. Corless, Jonathan A. Fletcher, Laura McGreevey, Andrea Haley, Diana J. Griffith, Oscar W. Cummings, Cecily L. Wait, Ajia Town, Michael ...> ;The American Journal of Pathology. 2004 Jan 1
• 48 citations
  Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors
  A. Madani, Kathleen Kemmer, Christopher Sweeney, Christopher L. Corless, Thomas M. Ulbright, Michael Heinrich, Lawrence H. Einhorn> ;Annals of Oncology. 2003 Jun 1
• 8 citations
  Growth of Neonatal Islet Transplants in the Spontaneously Diabetic BB/Wor Rat
  Janet R. Serie, Hanna N. Cooper, Kathleen A Kemmer, Orion D. Hegre> ;Diabetes. 1992 Sep 1
• Join now to see all